Hong Cheng

26PUBLICATIONS
3CO-AUTHORS
Pharmaceutical delivery technologiesMedical devicesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Mar 12, 2026
Stearic acid-modified PSMA-targeting peptide-drug conjugate for long-acting prostate cancer therapy.

Ziwen Qiu, Xiaorui Zheng, Shoumei Pan

|Aug 12, 2025
A Self-Delivering Oxygen Modulator for Breast Cancer Immunotherapy via Pyroptosis Induction and PD-L1 Degradation.

Jun-Mei Nie, Yan-Mei Li, Ke-Yan Zhang

|Aug 01, 2025
Lymph node-targeted metabolic regulatory nanovaccines to boost cancer immunotherapy by potentiating dendritic cell-mediated antigen presentation.

Yingtao Zhong, Ziwen Qiu, Keyan Zhang

|Mar 25, 2025
PD-L1-Targeting Autophagy Modulator to Upregulate MHC-I and Activate Photo-Immunotherapy for Metastatic Tumor Eradication.

Zhen-Ming Lu, Zi-Wen Qiu, Yan-Mei Li

|Feb 27, 2025
Plasma Membrane Targeted Photodynamic Nanoagonist to Potentiate Immune Checkpoint Blockade Therapy by Initiating Tumor Cell Pyroptosis and Depleting Infiltrating B Cells.

Ying-Tao Zhong, Zi-Wen Qiu, Ke-Yan Zhang

|Apr 23, 2024
Neuropilin-1-Targeted Nanomedicine for Spatiotemporal Tumor Suppression through Photodynamic Vascular Damage and Antiangiogenesis.

Xin-Yu Li, Ni Yan, Ye-Yang Wu

Pageof 5

Frequent Collaborators

16 joint publications

Shiying Li

1 joint publications

Ying-Ling Miao

1 joint publications

Youzhi Tang